GLP-1 weight loss drugs like Ozempic, Wegovy, and Mounjaro are reshaping the food industry as millions of users report dramatically reduced appetites and changed food preferences.
Industry Impact
- Snack food sales down 3.2% in Q1 2026
- Alcohol consumption among GLP-1 users dropped 40%
- Fast food visits by GLP-1 users declined 25%
- Protein-rich food sales surged 8%
How GLP-1 Drugs Affect Eating
Users report reduced cravings for sugar and processed foods, feeling full faster, and decreased interest in alcohol. Some describe a fundamental change in their relationship with food.
Food Companies Respond
Nestle, PepsiCo, and Kraft Heinz have launched GLP-1-friendly product lines with higher protein and smaller portions. Restaurants are introducing smaller plate options catering to reduced appetites.
